Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence

Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence have?

Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence has 8 citations in the OpenAlex counts ScholarIQ stores.

When was Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence published?

Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence has 2025 year in the ScholarIQ index.

What is the open-access status of Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence?

Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence has hybrid oa status in the ScholarIQ index.

What is the DOI of Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence?

The DOI for Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence is on the source record.

What is the PMID of Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence?

The PMID for Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence is on the source record.

What is the OpenAlex record for Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence?

The OpenAlex for Obicetrapib and its impact on lipid parameters: A comprehensive meta-analysis of the latest evidence is on the source record.